263 related articles for article (PubMed ID: 27082701)
21. FDA Implements New Labeling for Medications Used During Pregnancy and Lactation.
Whyte J
Am Fam Physician; 2016 Jul; 94(1):12-5. PubMed ID: 27386718
[No Abstract] [Full Text] [Related]
22. Proposed US Food and Drug Administration guidance for industry on distributing medical publications about the risks of prescription drugs and biological products: a misguided approach.
Wolfe SM
JAMA Intern Med; 2014 Oct; 174(10):1543-4. PubMed ID: 25127222
[No Abstract] [Full Text] [Related]
23. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century.
Kweder SL
Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917
[No Abstract] [Full Text] [Related]
24. Introduction to the new prescription drug labeling by the Food and Drug Administration.
Lal R; Kremzner M
Am J Health Syst Pharm; 2007 Dec; 64(23):2488-94. PubMed ID: 18029957
[TBL] [Abstract][Full Text] [Related]
25. Recent changes in pregnancy and lactation labeling: retirement of risk categories.
Ramoz LL; Patel-Shori NM
Pharmacotherapy; 2014; 34(4):389-95. PubMed ID: 24390829
[TBL] [Abstract][Full Text] [Related]
26. Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
Yeh JS; Sarpatwari A; Kesselheim AS
Drug Saf; 2016 Aug; 39(8):709-14. PubMed ID: 27000800
[TBL] [Abstract][Full Text] [Related]
27. Psychiatric Medications and Reproductive Safety: Scientific and Clinical Perspectives Pertaining to the US FDA Pregnancy and Lactation Labeling Rule.
Freeman MP; Farchione T; Yao L; Sahin L; Taylor L; Huybrechts KF; Nonacs R; Sosinsky AZ; Viguera AC; Cohen LS
J Clin Psychiatry; 2018 Jul; 79(4):. PubMed ID: 30153401
[TBL] [Abstract][Full Text] [Related]
28. Medication use during pregnancy and lactation: the new FDA drug labeling.
Tillett J
J Perinat Neonatal Nurs; 2015; 29(2):97-9. PubMed ID: 25919597
[No Abstract] [Full Text] [Related]
29. [Information on the risk of drugs in pregnancy: New regulation of the Food and Drug Administration].
García Caeiro ÁL; Rey Liste MT; Ventosa Rial JJ; Alonso Fachado A
Aten Primaria; 2017 Dec; 49(10):622-623. PubMed ID: 28844480
[No Abstract] [Full Text] [Related]
30. A Comparison of FDA and EMA Pregnancy and Lactation Labeling.
Kappel D; Sahin L; Yao L; Thor S; Kweder S
Clin Pharmacol Ther; 2023 Jun; 113(6):1251-1257. PubMed ID: 36645246
[TBL] [Abstract][Full Text] [Related]
31. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
[TBL] [Abstract][Full Text] [Related]
32. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule.
Fed Regist; 1998 Dec; 63(231):66631-72. PubMed ID: 10338880
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary.
Wang J; Johnson T; Sahin L; Tassinari MS; Anderson PO; Baker TE; Bucci-Rechtweg C; Burckart GJ; Chambers CD; Hale TW; Johnson-Lyles D; Nelson RM; Nguyen C; Pica-Branco D; Ren Z; Sachs H; Sauberan J; Zajicek A; Ito S; Yao LP
Clin Pharmacol Ther; 2017 Jun; 101(6):736-744. PubMed ID: 28510297
[TBL] [Abstract][Full Text] [Related]
34. The new US Food and Drug Administration pregnancy and lactation labeling rules: Their impact on clinical practice.
Danesh MJ; Murase JE
J Am Acad Dermatol; 2015 Aug; 73(2):310-1. PubMed ID: 26183972
[No Abstract] [Full Text] [Related]
35. Categorizing the safety of medications during pregnancy and lactation.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2009 Apr; 47(4):17-20. PubMed ID: 19437927
[TBL] [Abstract][Full Text] [Related]
36. The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals.
Greene JA; Watkins ES
N Engl J Med; 2015 Sep; 373(12):1087-9. PubMed ID: 26287749
[No Abstract] [Full Text] [Related]
37. Characterization of the US Food and Drug Administration Post-Marketing Commitments and Requirements for Pregnancy and Lactation.
Avachat C; Younis IR; Birnbaum AK
Clin Pharmacol Ther; 2023 Dec; 114(6):1238-1242. PubMed ID: 37750407
[TBL] [Abstract][Full Text] [Related]
38. Drugs and lactation--another failure of product labeling.
Scialli AR
Reprod Toxicol; 1996; 10(2):91-2. PubMed ID: 8919604
[No Abstract] [Full Text] [Related]
39. Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease.
Mahadevan U; McConnell RA; Chambers CD
Gastroenterology; 2017 Feb; 152(2):451-462.e2. PubMed ID: 27769809
[TBL] [Abstract][Full Text] [Related]
40. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights October-December 2015.
Office of Health & Constituent Affairs U.S. Food and Drug Administration
Am J Health Syst Pharm; 2016 Mar; 73(5):267. PubMed ID: 26896495
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
